Trivium Point Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
|
|||||
|
2025
Q1 | $236K | Buy |
|
|||||
|
2024
Q4 | $253K | Sell |
|
|||||
|
2024
Q3 | $239K | Sell |
|
|||||
|
2024
Q2 | $429K | Sell |
|
|||||
|
2024
Q1 | $535K | Buy |
|
|||||
|
2023
Q4 | $471K | Buy |
|
|||||
|
2023
Q3 | $340K | Buy |
|
|||||
|
2023
Q2 | $446K | Sell |
|
|||||
|
2023
Q1 | $405K | Hold |
|
|||||
|
2022
Q4 | $403K | Sell |
|
|||||
|
2022
Q3 | $374K | Sell |
|
|||||
|
2022
Q2 | $328K | Sell |
|
|||||
|
2022
Q1 | $516K | Buy |
|
|||||
|
2021
Q4 | $500K | Sell |
|
|||||
|
2021
Q3 | $506K | Buy |
|
|||||
|
2021
Q2 | $364K | Buy |
|
|||||
|
2021
Q1 | $271K | Buy |
|
|||||
|
2020
Q4 | $233K | Buy |
|